Skip to Content

Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Download PQI pdf 0.87MB

Last Updated: October 9, 2025

By: Froedtert & Medical College of Wisconsin | Hematology-Oncology Associates of Central New York (HOA) | Mission Cancer + Blood

About this PQI in Action

This PQI in Action is a follow up to the Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma PQI and explores how the medically integrated teams at Froedtert & Medical College of Wisconsin (Froedtert), Hematology-Oncology Associates of Central New York (HOA) and Mission Cancer + Blood collaborate and utilize the information found in the PQI as part of their daily practice.